Screener
Amphastar Pharmaceuticals AMPH Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Net revenues | $183,903 | $174,414 | $355,074 | $344,942 |
| Cost of revenues | 90,433 | 87,924 | 191,282 | 173,201 |
| Gross profit | 93,470 | 86,490 | 163,792 | 171,741 |
| Operating expenses: | ||||
| Selling, distribution, and marketing | 13,335 | 10,235 | 25,262 | 22,101 |
| General and administrative | 18,242 | 13,991 | 36,270 | 29,987 |
| Research and development | 22,164 | 20,080 | 48,901 | 40,176 |
| Total operating expenses | 53,741 | 44,306 | 110,433 | 92,264 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Amphastar Pharmaceuticals's total revenue?
- Amphastar Pharmaceuticals (AMPH) reported total revenue of $183.9M in Q2 2026.
- How has Amphastar Pharmaceuticals's total revenue changed year-over-year?
- Amphastar Pharmaceuticals's total revenue increased by 5.4% year-over-year, from $174.41M to $183.9M.
- What is the long-term trend for Amphastar Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's total revenue has grown at a 13.2% compound annual growth rate (CAGR), from $437.77M to $719.89M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Amphastar Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude